Is this you?
Request access for Metabolic Research Institute with your @metabolic-institute.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Metabolic Research Institute
Unclaimed profileIndependent Site · West Palm Beach, FL · ~1 sites
Intera lens
ICP 6Lift (cardio sample) 0.14Recruit soph 0.86
Quality Scorecard (1–100)
Overall81Recruit80Ops83Sponsor84Ther75
Performance (observed)
Historical trials
331
Completed
213
Terminated/Withdrawn
25
Completion rate
89%
Active now
81
Phase 2
106
Phase 3
176
Realized enrollment
337,349
First study year
2001
Years active
25
Match confidence
low (approx)
Enrollment velocity (inf)
13,494
Therapeutic
Areas
Diabetes, Endocrine Disorders, Cardiovascular Disease, Fatty Liver (MASH), Graves Disease
Specialties
Diabetes (Type 1, Type 2), Obesity, Hypertension, Heart disease, Endocrine
Breadth (conditions)
214
Languages
Y; multilingual coordinators
States
Florida
Recruitment (web observed)
Meta Pixel
Yes
Facebook Ads
Yes
Trial Finder
Yes
Patient database
Y; 19,000+ patients
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Active recruitment; patient database 19,000+
Capability notes
High - emphasizes patient screening and enrollment for clinical trials
Relationships
Sponsors
Eli Lilly and Company; Novo Nordisk A/S; Pfizer; Boehringer Ingelheim; Gilead Sciences; Ionis Pharmaceuticals, Inc.
CROs
Ergomed GmbH; ICON plc; Medpace, Inc.; Worldwide Clinical Trials
Partnerships
Palm Beach Diabetes and Endocrine Specialists, P.A.
Owner / parent
Private; founded by Dr. William Kaye, MD
Expansion
Established 1996; operating 30+ years
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
acalderon@metabolic-institute.com, info@mri-news.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Single-location site in West Palm Beach, FL, founded 1996. Primary focus on diabetes/endocrinology research. ClinicalTrials.gov validation: 6 active recruiting cardiometabolic trials. Modest tech/CTMS disclosure. Shows patient recruitment capability through current studies. Leadership structure unclear beyond co-medical directors.
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.14Overall81
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.